Contact

Oncology.

Partnering with clients to advance life-saving oncology treatments.

Informed by insight. Driven by impact.

With over 30 years of deep-rooted oncology expertise, we turn knowledge into action, bringing clarity and precision to even the most complex therapeutic challenges. By accelerating the journey from breakthrough science to real-world impact, we help simplify the complex, unlock value, and enhance patient care. 

Get in touch

Why choose us as your trusted oncology partner?

We combine deep scientific expertise, data-driven insights, and tailored strategies to simplify oncology and drive smarter decisions at every pivotal moment of the journey.

Deep, broad expertise. Our oncology experts combine deep scientific knowledge with advanced data, technology, and AI-driven insights to drive smarter, faster decisions and deliver meaningful impact. 

Solution-oriented. We create tailored solutions that align scientific innovation with real-world patient needs – guiding clients through the oncology lifecycle with clarity and purpose. 

Easy to work with. We simplify even the most complex challenges by uniting medical, strategic, and engagement expertise to help deliver the right treatments to the right patients, faster. 

At the heart of oncology innovation.

Industry-leading oncology congresses like ASCO are where new evidence emerges, perspectives are challenged, and the future of cancer care takes shape. Inizio is there to help clients engage with the science, understand what matters most, and act on the insights that can drive better outcomes for patients.

Watch our ASCO 2026 recap

Our expertise.

Oncology is our largest therapeutic area for branded and strategic work. With deep therapeutic knowledge and a data-driven approach, we help shape impactful strategies across the oncology lifecycle. 

 

Based on internal revenue data and industry data available from EvaluatePharma (March, 2026).

%
of the top 20 oncology products supported in the last two years
%
of the projected top 20 oncology products are being worked on by our team currently
>
oncology assets supported in early pre-commercialization in 2024/5
>
small molecule oncology assets worked on in the last two years
%
of oncology launches backed by our expertise in the last two years
> %
of marketed oncology assets supported in the last two years

The latest in oncology.

Explore the latest oncology insights and uncover how emerging science, shifting treatment landscapes, and real-world challenges are shaping the future of cancer care.

Your market-leading commercialization partner.

Leveraging our connected suite of capabilities, our experts will guide you through each pivotal moment in your asset’s lifecycle, creating tailored solutions that simplify the complex, unlock value, and enhance treatment outcomes.

Speak to one of our team